Global Companion Diagnostic Tests in Oncology Market Research Report 2024

Report ID: 1990848 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Protein Detection
        1.2.3 DNA Detection
    1.3 Market by Application
        1.3.1 Global Companion Diagnostic Tests in Oncology Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Pharmaceutical & Biotechnology Companies
        1.3.3 Medical Device Companies
        1.3.4 Research Institutes
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Companion Diagnostic Tests in Oncology Market Perspective (2017-2028)
    2.2 Companion Diagnostic Tests in Oncology Growth Trends by Region
        2.2.1 Companion Diagnostic Tests in Oncology Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Companion Diagnostic Tests in Oncology Historic Market Size by Region (2017-2022)
        2.2.3 Companion Diagnostic Tests in Oncology Forecasted Market Size by Region (2023-2028)
    2.3 Companion Diagnostic Tests in Oncology Market Dynamics
        2.3.1 Companion Diagnostic Tests in Oncology Industry Trends
        2.3.2 Companion Diagnostic Tests in Oncology Market Drivers
        2.3.3 Companion Diagnostic Tests in Oncology Market Challenges
        2.3.4 Companion Diagnostic Tests in Oncology Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue
        3.1.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue (2017-2022)
        3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2017-2022)
    3.2 Global Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Companion Diagnostic Tests in Oncology Revenue
    3.4 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio
        3.4.1 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests in Oncology Revenue in 2021
    3.5 Companion Diagnostic Tests in Oncology Key Players Head office and Area Served
    3.6 Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
    3.7 Date of Enter into Companion Diagnostic Tests in Oncology Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Tests in Oncology Breakdown Data by Type
    4.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Type (2017-2022)
    4.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2023-2028)
5 Companion Diagnostic Tests in Oncology Breakdown Data by Application
    5.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Application (2017-2022)
    5.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Companion Diagnostic Tests in Oncology Market Size (2017-2028)
    6.2 North America Companion Diagnostic Tests in Oncology Market Size by Country (2017-2022)
    6.3 North America Companion Diagnostic Tests in Oncology Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Companion Diagnostic Tests in Oncology Market Size (2017-2028)
    7.2 Europe Companion Diagnostic Tests in Oncology Market Size by Country (2017-2022)
    7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size (2017-2028)
    8.2 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Country (2017-2022)
    8.3 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Companion Diagnostic Tests in Oncology Market Size (2017-2028)
    9.2 Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2017-2022)
    9.3 Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size (2017-2028)
    10.2 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2017-2022)
    10.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Detail
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Companion Diagnostic Tests in Oncology Introduction
        11.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022)
        11.1.5 Abbott Recent Development
    11.2 Roche
        11.2.1 Roche Company Detail
        11.2.2 Roche Business Overview
        11.2.3 Roche Companion Diagnostic Tests in Oncology Introduction
        11.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022)
        11.2.5 Roche Recent Development
    11.3 Genomic Health
        11.3.1 Genomic Health Company Detail
        11.3.2 Genomic Health Business Overview
        11.3.3 Genomic Health Companion Diagnostic Tests in Oncology Introduction
        11.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022)
        11.3.5 Genomic Health Recent Development
    11.4 QIAGEN
        11.4.1 QIAGEN Company Detail
        11.4.2 QIAGEN Business Overview
        11.4.3 QIAGEN Companion Diagnostic Tests in Oncology Introduction
        11.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022)
        11.4.5 QIAGEN Recent Development
    11.5 Agilent
        11.5.1 Agilent Company Detail
        11.5.2 Agilent Business Overview
        11.5.3 Agilent Companion Diagnostic Tests in Oncology Introduction
        11.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022)
        11.5.5 Agilent Recent Development
    11.6 Agendia
        11.6.1 Agendia Company Detail
        11.6.2 Agendia Business Overview
        11.6.3 Agendia Companion Diagnostic Tests in Oncology Introduction
        11.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022)
        11.6.5 Agendia Recent Development
    11.7 BioMerieux
        11.7.1 BioMerieux Company Detail
        11.7.2 BioMerieux Business Overview
        11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Introduction
        11.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022)
        11.7.5 BioMerieux Recent Development
    11.8 Illumina
        11.8.1 Illumina Company Detail
        11.8.2 Illumina Business Overview
        11.8.3 Illumina Companion Diagnostic Tests in Oncology Introduction
        11.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022)
        11.8.5 Illumina Recent Development
    11.9 Siemens Healthcare
        11.9.1 Siemens Healthcare Company Detail
        11.9.2 Siemens Healthcare Business Overview
        11.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Introduction
        11.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022)
        11.9.5 Siemens Healthcare Recent Development
    11.10 Thermo Fisher
        11.10.1 Thermo Fisher Company Detail
        11.10.2 Thermo Fisher Business Overview
        11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Introduction
        11.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022)
        11.10.5 Thermo Fisher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Protein Detection
    Table 3. Key Players of DNA Detection
    Table 4. Global Companion Diagnostic Tests in Oncology Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Companion Diagnostic Tests in Oncology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Companion Diagnostic Tests in Oncology Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Companion Diagnostic Tests in Oncology Market Share by Region (2017-2022)
    Table 8. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Companion Diagnostic Tests in Oncology Market Share by Region (2023-2028)
    Table 10. Companion Diagnostic Tests in Oncology Market Trends
    Table 11. Companion Diagnostic Tests in Oncology Market Drivers
    Table 12. Companion Diagnostic Tests in Oncology Market Challenges
    Table 13. Companion Diagnostic Tests in Oncology Market Restraints
    Table 14. Global Companion Diagnostic Tests in Oncology Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Companion Diagnostic Tests in Oncology Market Share by Players (2017-2022)
    Table 16. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2021)
    Table 17. Ranking of Global Top Companion Diagnostic Tests in Oncology Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Tests in Oncology Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
    Table 21. Date of Enter into Companion Diagnostic Tests in Oncology Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Companion Diagnostic Tests in Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2017-2022)
    Table 25. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2023-2028)
    Table 27. Global Companion Diagnostic Tests in Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2017-2022)
    Table 29. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2023-2028)
    Table 31. North America Companion Diagnostic Tests in Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Companion Diagnostic Tests in Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Companion Diagnostic Tests in Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Companion Diagnostic Tests in Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Abbott Company Detail
    Table 42. Abbott Business Overview
    Table 43. Abbott Companion Diagnostic Tests in Oncology Product
    Table 44. Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022) & (US$ Million)
    Table 45. Abbott Recent Development
    Table 46. Roche Company Detail
    Table 47. Roche Business Overview
    Table 48. Roche Companion Diagnostic Tests in Oncology Product
    Table 49. Roche Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022) & (US$ Million)
    Table 50. Roche Recent Development
    Table 51. Genomic Health Company Detail
    Table 52. Genomic Health Business Overview
    Table 53. Genomic Health Companion Diagnostic Tests in Oncology Product
    Table 54. Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022) & (US$ Million)
    Table 55. Genomic Health Recent Development
    Table 56. QIAGEN Company Detail
    Table 57. QIAGEN Business Overview
    Table 58. QIAGEN Companion Diagnostic Tests in Oncology Product
    Table 59. QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022) & (US$ Million)
    Table 60. QIAGEN Recent Development
    Table 61. Agilent Company Detail
    Table 62. Agilent Business Overview
    Table 63. Agilent Companion Diagnostic Tests in Oncology Product
    Table 64. Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022) & (US$ Million)
    Table 65. Agilent Recent Development
    Table 66. Agendia Company Detail
    Table 67. Agendia Business Overview
    Table 68. Agendia Companion Diagnostic Tests in Oncology Product
    Table 69. Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022) & (US$ Million)
    Table 70. Agendia Recent Development
    Table 71. BioMerieux Company Detail
    Table 72. BioMerieux Business Overview
    Table 73. BioMerieux Companion Diagnostic Tests in Oncology Product
    Table 74. BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022) & (US$ Million)
    Table 75. BioMerieux Recent Development
    Table 76. Illumina Company Detail
    Table 77. Illumina Business Overview
    Table 78. Illumina Companion Diagnostic Tests in Oncology Product
    Table 79. Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022) & (US$ Million)
    Table 80. Illumina Recent Development
    Table 81. Siemens Healthcare Company Detail
    Table 82. Siemens Healthcare Business Overview
    Table 83. Siemens Healthcare Companion Diagnostic Tests in Oncology Product
    Table 84. Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022) & (US$ Million)
    Table 85. Siemens Healthcare Recent Development
    Table 86. Thermo Fisher Company Detail
    Table 87. Thermo Fisher Business Overview
    Table 88. Thermo Fisher Companion Diagnostic Tests in Oncology Product
    Table 89. Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2017-2022) & (US$ Million)
    Table 90. Thermo Fisher Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Companion Diagnostic Tests in Oncology Market Share by Type: 2021 VS 2028
    Figure 2. Protein Detection Features
    Figure 3. DNA Detection Features
    Figure 4. Global Companion Diagnostic Tests in Oncology Market Share by Application in 2021 & 2028
    Figure 5. Pharmaceutical & Biotechnology Companies Case Studies
    Figure 6. Medical Device Companies Case Studies
    Figure 7. Research Institutes Case Studies
    Figure 8. Others Case Studies
    Figure 9. Companion Diagnostic Tests in Oncology Report Years Considered
    Figure 10. Global Companion Diagnostic Tests in Oncology Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Companion Diagnostic Tests in Oncology Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Companion Diagnostic Tests in Oncology Market Share by Region: 2021 VS 2028
    Figure 13. Global Companion Diagnostic Tests in Oncology Market Share by Players in 2021
    Figure 14. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Companion Diagnostic Tests in Oncology Revenue in 2021
    Figure 16. North America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Companion Diagnostic Tests in Oncology Market Share by Country (2017-2028)
    Figure 18. United States Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Companion Diagnostic Tests in Oncology Market Share by Country (2017-2028)
    Figure 22. Germany Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Companion Diagnostic Tests in Oncology Market Share by Region (2017-2028)
    Figure 30. China Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Companion Diagnostic Tests in Oncology Market Share by Country (2017-2028)
    Figure 38. Mexico Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Companion Diagnostic Tests in Oncology Market Share by Country (2017-2028)
    Figure 42. Turkey Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Abbott Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2017-2022)
    Figure 45. Roche Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2017-2022)
    Figure 46. Genomic Health Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2017-2022)
    Figure 47. QIAGEN Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2017-2022)
    Figure 48. Agilent Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2017-2022)
    Figure 49. Agendia Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2017-2022)
    Figure 50. BioMerieux Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2017-2022)
    Figure 51. Illumina Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2017-2022)
    Figure 52. Siemens Healthcare Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2017-2022)
    Figure 53. Thermo Fisher Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Roche
Genomic Health
QIAGEN
Agilent
Agendia
BioMerieux
Illumina
Siemens Healthcare
Thermo Fisher
Frequently Asked Questions
Companion Diagnostic Tests in Oncology report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Companion Diagnostic Tests in Oncology report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Companion Diagnostic Tests in Oncology report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Condiment Sauces

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Conditioning Agent

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More